Tuberculosis (TB) Treatment Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Publish Date : 2021-03-14 | Publisher : 99Strategy | No Of Page : 97 | Report Id : MRB000117070 |

   

Report

MRB

Tuberculosis (TB) Treatment Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Publish Date: 2021-03-14 No Of Page: 97 Report Id: MRB000117070 Publisher: 99Strategy Category: Medical Care

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use Chapter 8: South America Market Segmentation by region, type and End-Use Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use. Chapter 10: Market Competition by Companies Chapter 11: Market forecast and environment forecast. Chapter 12: Industry Summary. The global Tuberculosis (TB) Treatment market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics. Based on the type of product, the global Tuberculosis (TB) Treatment market segmented into Isoniazid Rifampin (Rifadin, Rimactane) Ethambutol (Myambutol) Pyrazinamide Based on the end-use, the global Tuberculosis (TB) Treatment market classified into Active TB Latent TB Based on geography, the global Tuberculosis (TB) Treatment market segmented into North America [U.S., Canada, Mexico] Europe [Germany, UK, France, Italy, Rest of Europe] Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific] South America [Brazil, Argentina, Rest of Latin America] Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa] And the major players included in the report are Johnson & Johnson Otsuka Pharmaceutical Co., Ltd Macleods Pharmaceutical Ltd Dong-A ST Co., Ltd Lupin Ltd Janssen Products, LP Mylan Sanofi

Table of Contents 1 RESEARCH SCOPE 1.1 Research Product Definition 1.2 Research Segmentation 1.2.1 Product Type 1.2.2 Main product Type of Major Players 1.3 Demand Overview 1.4 Research Methodology 2 GLOBAL TUBERCULOSIS (TB) TREATMENT INDUSTRY 2.1 Summary about Tuberculosis (TB) Treatment Industry 2.2 Tuberculosis (TB) Treatment Market Trends 2.2.1 Tuberculosis (TB) Treatment Production & Consumption Trends 2.2.2 Tuberculosis (TB) Treatment Demand Structure Trends 2.3 Tuberculosis (TB) Treatment Cost & Price 3 MARKET DYNAMICS 3.1 Manufacturing & Purchasing Behavior in 2020 3.2 Market Development under the Impact of COVID-19 3.2.1 Drivers 3.2.2 Restraints 3.2.3 Opportunity 3.2.4 Risk 4 GLOBAL MARKET SEGMENTATION 4.1 Region Segmentation (2017 to 2021f) 4.1.1 North America (U.S., Canada and Mexico) 4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe) 4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific) 4.1.4 South America (Brazil,, Argentina, Rest of Latin America) 4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa) 4.2 Product Type Segmentation (2017 to 2021f) 4.2.1 Isoniazid 4.2.2 Rifampin (Rifadin, Rimactane) 4.2.3 Ethambutol (Myambutol) 4.2.4 Pyrazinamide 4.3 Consumption Segmentation (2017 to 2021f) 4.3.1 Active TB 4.3.2 Latent TB 5 NORTH AMERICA MARKET SEGMENT 5.1 Region Segmentation (2017 to 2021f) 5.1.1 U.S. 5.1.2 Canada 5.1.3 Mexico 5.2 Product Type Segmentation (2017 to 2021f) 5.2.1 Isoniazid 5.2.2 Rifampin (Rifadin, Rimactane) 5.2.3 Ethambutol (Myambutol) 5.2.4 Pyrazinamide 5.3 Consumption Segmentation (2017 to 2021f) 5.3.1 Active TB 5.3.2 Latent TB 5.4 Impact of COVID-19 in North America 6 EUROPE MARKET SEGMENTATION 6.1 Region Segmentation (2017 to 2021f) 6.1.1 Germany 6.1.2 UK 6.1.3 France 6.1.4 Italy 6.1.5 Rest of Europe 6.2 Product Type Segmentation (2017 to 2021f) 6.2.1 Isoniazid 6.2.2 Rifampin (Rifadin, Rimactane) 6.2.3 Ethambutol (Myambutol) 6.2.4 Pyrazinamide 6.3 Consumption Segmentation (2017 to 2021f) 6.3.1 Active TB 6.3.2 Latent TB 6.4 Impact of COVID-19 in Europe 7 ASIA-PACIFIC MARKET SEGMENTATION 7.1 Region Segmentation (2017 to 2021f) 7.1.1 China 7.1.2 India 7.1.3 Japan 7.1.4 South Korea 7.1.5 Southeast Asia 7.1.6 Australia 7.1.7 Rest of Asia Pacific 7.2 Product Type Segmentation (2017 to 2021f) 7.2.1 Isoniazid 7.2.2 Rifampin (Rifadin, Rimactane) 7.2.3 Ethambutol (Myambutol) 7.2.4 Pyrazinamide 7.3 Consumption Segmentation (2017 to 2021f) 7.3.1 Active TB 7.3.2 Latent TB 7.4 Impact of COVID-19 in Europe 8 SOUTH AMERICA MARKET SEGMENTATION 8.1 Region Segmentation (2017 to 2021f) 8.1.1 Brazil 8.1.2 Argentina 8.1.3 Rest of Latin America 8.2 Product Type Segmentation (2017 to 2021f) 8.2.1 Isoniazid 8.2.2 Rifampin (Rifadin, Rimactane) 8.2.3 Ethambutol (Myambutol) 8.2.4 Pyrazinamide 8.3 Consumption Segmentation (2017 to 2021f) 8.3.1 Active TB 8.3.2 Latent TB 8.4 Impact of COVID-19 in Europe 9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION 9.1 Region Segmentation (2017 to 2021f) 9.1.1 GCC 9.1.2 North Africa 9.1.3 South Africa 9.1.4 Rest of Middle East and Africa 9.2 Product Type Segmentation (2017 to 2021f) 9.2.1 Isoniazid 9.2.2 Rifampin (Rifadin, Rimactane) 9.2.3 Ethambutol (Myambutol) 9.2.4 Pyrazinamide 9.3 Consumption Segmentation (2017 to 2021f) 9.3.1 Active TB 9.3.2 Latent TB 9.4 Impact of COVID-19 in Europe 10 COMPETITION OF MAJOR PLAYERS 10.1 Brief Introduction of Major Players 10.1.1 Johnson & Johnson 10.1.2 Otsuka Pharmaceutical Co., Ltd 10.1.3 Macleods Pharmaceutical Ltd 10.1.4 Dong-A ST Co., Ltd 10.1.5 Lupin Ltd 10.1.6 Janssen Products, LP 10.1.7 Mylan 10.1.8 Sanofi 10.2 Tuberculosis (TB) Treatment Sales Date of Major Players (2017-2020e) 10.2.1 Johnson & Johnson 10.2.2 Otsuka Pharmaceutical Co., Ltd 10.2.3 Macleods Pharmaceutical Ltd 10.2.4 Dong-A ST Co., Ltd 10.2.5 Lupin Ltd 10.2.6 Janssen Products, LP 10.2.7 Mylan 10.2.8 Sanofi 10.3 Market Distribution of Major Players 10.4 Global Competition Segmentation 11 MARKET FORECAST 11.1 Forecast by Region 11.2 Forecast by Demand 11.3 Environment Forecast 11.3.1 Impact of COVID-19 11.3.2 Geopolitics Overview 11.3.3 Economic Overview of Major Countries 12 REPORT SUMMARY STATEMENT

List of Table 1.Table Tuberculosis (TB) Treatment Product Type Overview 2.Table Tuberculosis (TB) Treatment Product Type Market Share List 3.Table Tuberculosis (TB) Treatment Product Type of Major Players 4.Table Brief Introduction of Johnson & Johnson 5.Table Brief Introduction of Otsuka Pharmaceutical Co., Ltd 6.Table Brief Introduction of Macleods Pharmaceutical Ltd 7.Table Brief Introduction of Dong-A ST Co., Ltd 8.Table Brief Introduction of Lupin Ltd 9.Table Brief Introduction of Janssen Products, LP 10.Table Brief Introduction of Mylan 11.Table Brief Introduction of Sanofi 12.Table Products & Services of Johnson & Johnson 13.Table Products & Services of Otsuka Pharmaceutical Co., Ltd 14.Table Products & Services of Macleods Pharmaceutical Ltd 15.Table Products & Services of Dong-A ST Co., Ltd 16.Table Products & Services of Lupin Ltd 17.Table Products & Services of Janssen Products, LP 18.Table Products & Services of Mylan 19.Table Products & Services of Sanofi 20.Table Market Distribution of Major Players 21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e 22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e 23.Table Global Tuberculosis (TB) Treatment Market Forecast (Million USD) by Region 2021f-2026f 24.Table Global Tuberculosis (TB) Treatment Market Forecast (Million USD) Share by Region 2021f-2026f 25.Table Global Tuberculosis (TB) Treatment Market Forecast (Million USD) by Demand 2021f-2026f 26.Table Global Tuberculosis (TB) Treatment Market Forecast (Million USD) Share by Demand 2021f-2026f

Mycobacterium Tuberculosis Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segme ...
Published Date :  2021-03-14

Latent Tuberculosis Infection (LTBI) Testing Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segme ...
Published Date :  2021-03-14

2015-2025 Global Latent Tuberculosis Infection (LTBI) Testing Market Research by Type, End-Use and Region (COVID-19 Version)

Summary The global Latent Tuberculosis Infection (LTBI) Testing market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Mark ...
Published Date :  2020-10-20

2015-2025 Global Tuberculosis (TB) Treatment Market Research by Type, End-Use and Region

Summary The global Tuberculosis (TB) Treatment market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and ...
Published Date :  2020-10-20

2015-2025 Global Mycobacterium Tuberculosis Market Research by Type, End-Use and Region (COVID-19 Version)

Summary The global Mycobacterium Tuberculosis market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and ...
Published Date :  2020-10-20